Search Results - "Raeve, Hendrik De"
-
1
The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma
Published in Oncotarget (30-05-2014)“…DNA methyltransferase inhibitors (DNMTi) and histone deacetylase inhibitors (HDACi) are under investigation for the treatment of cancer, including the plasma…”
Get full text
Journal Article -
2
Zoledronic Acid Treatment of 5T2MM‐Bearing Mice Inhibits the Development of Myeloma Bone Disease: Evidence for Decreased Osteolysis, Tumor Burden and Angiogenesis, and Increased Survival
Published in Journal of bone and mineral research (01-03-2003)“…Multiple myeloma is characterized by the growth of plasma cells in the bone marrow and the development of osteolytic bone disease. Myeloma cells are found…”
Get full text
Journal Article -
3
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study
Published in Oncotarget (02-03-2018)Get full text
Journal Article -
4
Metachronous metastasis of renal cell carcinoma to the urinary bladder: a case report
Published in Therapeutic advances in urology (01-01-2018)“…We report a case of intravesical metastasis of a clear cell renal cell carcinoma. In renal cell carcinoma 16% of patients present with metastatic disease…”
Get full text
Journal Article -
5
Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
Published in Blood cancer journal (New York) (08-11-2018)“…Progression of multiple myeloma (MM) is largely dependent on the bone marrow (BM) microenvironment wherein communication through different factors including…”
Get full text
Journal Article Web Resource -
6
Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma
Published in Oncotarget (21-06-2016)“…Multiple myeloma (MM) is a plasma cell malignancy characterized by the accumulation of tumor cells in the bone marrow (BM) and is associated with…”
Get full text
Journal Article Web Resource -
7
ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation
Published in Stem cell research & therapy (30-11-2020)“…Bone destruction is a hallmark of multiple myeloma (MM). It has been reported that proteasome inhibitors (PIs) can reduce bone resorption and increase bone…”
Get full text
Journal Article -
8
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma
Published in British journal of cancer (11-06-2019)“…Background The aggressive B-cell non-Hodgkin lymphomas diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) are characterised by a high…”
Get full text
Journal Article -
9
Synergistic induction of apoptosis in multiple myeloma cells by bortezomib and hypoxia-activated prodrug TH-302, in vivo and in vitro
Published in Molecular cancer therapeutics (01-09-2013)“…Recently, we showed that hypoxia is a critical microenvironmental factor in multiple myeloma, and that the hypoxia-activated prodrug TH-302 selectively targets…”
Get full text
Journal Article -
10
Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond
Published in Acta haematologica (01-01-2015)“…The Polycythemia Vera Study Group (PVSG) and WHO classifications distinguished the Philadelphia (Ph(1)) chromosome-positive chronic myeloid leukemia from the…”
Get more information
Journal Article -
11
Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model
Published in Clinical & experimental metastasis (01-11-2006)“…Multiple myeloma (MM) is a plasma cell malignancy, characterized by the localization of the MM cells in the bone marrow (BM), where they proliferate and induce…”
Get full text
Journal Article -
12
Reproducibility of Histologic Classification in Nonfibrotic Myeloproliferative Neoplasia
Published in American journal of clinical pathology (01-10-2011)“…Early phases of polycythemia vera, essential thrombocythemia, and primary myelofibrosis (PMF) can be difficult to distinguish by morphologic studies alone…”
Get full text
Journal Article -
13
Targeting the IGF‐1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: Beneficial effects on tumor growth, angiogenesis, bone disease and survival
Published in International journal of cancer (15-10-2007)“…During the last decade, a central role for insulin‐like growth factor 1 (IGF‐1) in the pathophysiology of multiple myeloma (MM) has been well established…”
Get full text
Journal Article -
14
Extension of 2016 World Health Organization (WHO) Classification into a New Set of Clinical, Laboratory, Molecular, and Pathological Criteria for the Diagnosis of Myeloproliferative Neoplasms: From Dameshek to Vainchenker, Green, and Kralovics
Published in European Medical Journal (Chelmsford, England) (01-07-2017)“…Improved Clinical, Laboratory, Molecular, and Pathological (CLMP) 2017 criteria for myeloproliferative neoplasms (MPN) define the JAK2V617F trilinear MPNs as a…”
Get full text
Journal Article -
15
Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications
Published in Seminars in thrombosis and hemostasis (01-04-2006)“…Microvascular disturbances in essential thrombocythemia (ET) and polycythemia vera (PV), including erythromelalgia, and atypical and typical transient…”
Get more information
Journal Article -
16
An unexpected complication of chronic myelomonocytic leukemia: severe renal failure due to malignant tubulo-interstitial cell infiltration
Published in International journal of nephrology and renovascular disease (01-01-2016)“…Acute renal failure may complicate the course of a hematologic malignancy but is a highly unusual finding in patients with chronic myelomonocytic leukemia…”
Get full text
Journal Article -
17
WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders
Published in Leukemia research (01-08-2007)“…Abstract The bone marrow criteria defined by the World Health Organization (WHO) are based on characteristic increase and clustering of morphologically…”
Get full text
Journal Article -
18
Eosinophilic Fasciitis: an Atypical Presentation of a Rare Disease
Published in European journal of case reports in internal medicine (03-04-2015)“…Objectives: We report an atypical presentation of eosinophilic fasciitis and provide a concise overview of the literature. Materials and Methods: Clinical and…”
Get full text
Journal Article -
19
The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2V617F Mutation
Published in Turkish journal of haematology (05-09-2014)“…Objective: The prefibrotic stages of JAK2V617F essential thrombocythemia (ET) and JAK2V617F polycythemia vera (PV) can easily be diagnosed clinically without…”
Get full text
Journal Article -
20
Recurrent Myasthenia Gravis Due to a Pleural Implant 3 Years After Radical Thymectomy
Published in The Annals of thoracic surgery (01-07-2008)“…Although recurrence of a thymoma is rare, pleural dissemination or local relapses have been described. We present a patient who underwent complete thymectomy…”
Get full text
Journal Article